"たけだP" の関連情報検索結果
Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide ...

Earnings Tell The Story For Takeda Pharmaceutical Company Limited (TSE:4502) - simplywall.st

Earnings Tell The Story For Takeda Pharmaceutical Company Limited (TSE:4502) simplywall.st
Korean pharmas race for generic P-CAB market amid Takeda's uncertain future for Vocinti - koreabi...

Korean pharmas race for generic P-CAB market amid Takeda's uncertain future for Vocinti koreabiomed.com
Korean drug Kecap advances toward U.S. approval, challenging Takeda's Boeqezna - CHOSUNBIZ - Chos...

Korean drug Kecap advances toward U.S. approval, challenging Takeda's Boeqezna - CHOSUNBIZ Chosunbiz
Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures - BioSpace

Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures BioSpace
Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlest...

Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat GlobeNewswire
Takeda’s market exit and return of vonoprazan raise stakes in Korea’s drug pricing battle - korea...

Takeda’s market exit and return of vonoprazan raise stakes in Korea’s drug pricing battle koreabiomed.com
Zydus Licenses Takeda's GERD Drug Vonoprazan for India - Rediff MoneyWiz

Zydus Licenses Takeda's GERD Drug Vonoprazan for India Rediff MoneyWiz
Takeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndro...

Zydus ties with Takeda to sell GERD drug - Mint

Torrent Pharma, Takeda to commercialise GI drug in India - Times of India

Torrent Pharma, Takeda to commercialise GI drug in India Times of India
Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India - Business Standard

Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India Business Standard
Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now? - Yahoo Finance

Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now? Yahoo Finance
Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on t...

Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on the shelf Fierce Biotech
Takeda taps Julie Kim as next CEO, 1st Korean American to lead global pharma company - koreabiome...

Takeda taps Julie Kim as next CEO, 1st Korean American to lead global pharma company koreabiomed.com
Torrent Pharma in pact with Takeda to commercialize acid reflux drug - Mint

Torrent Pharma in pact with Takeda to commercialize acid reflux drug Mint
Torrent Pharma Licenses Vonoprazan GERD Drug from Takeda - Rediff MoneyWiz

Torrent Pharma Licenses Vonoprazan GERD Drug from Takeda Rediff MoneyWiz
Takeda's Poseida partnership starts to pay off with promising hemophilia A gene therapy data - Fi...

Takeda's Poseida partnership starts to pay off with promising hemophilia A gene therapy data Fierce Biotech
Takeda powers toward pivotal trials after phase 2b narcolepsy win but pauses multi-indication dre...

Takeda powers toward pivotal trials after phase 2b narcolepsy win but pauses multi-indication dream Fierce Biotech
Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data d...

Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data detail Fierce Biotech
Neurocrine’s Takeda-Partnered Drug Candidate Aces Phase II Depression Study - BioSpace

Neurocrine’s Takeda-Partnered Drug Candidate Aces Phase II Depression Study BioSpace
Zydus announces non-exclusive patent licensing agreement with Takeda for ‘Vault’ (Vonoprazan) in ...

Zydus announces non-exclusive patent licensing agreement with Takeda for ‘Vault’ (Vonoprazan) in India Express Pharma
Lymphocytopenia following adjuvant radiotherapy for breast cancer - Takeda - 2024 - Precision Rad...

Lymphocytopenia following adjuvant radiotherapy for breast cancer - Takeda - 2024 - Precision Radiation Oncology Wiley Online Library
Takeda's Oncology Chief Joins Lantheus Board: Major Win for Radiopharmaceutical Pipeline - Stock ...

Takeda's Oncology Chief Joins Lantheus Board: Major Win for Radiopharmaceutical Pipeline Stock Titan
Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock? - Nasdaq

Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock? Nasdaq
Recon: Takeda CEO Weber to step down; Merck halts PAH drug trial early on strong efficacy data - ...

Recon: Takeda CEO Weber to step down; Merck halts PAH drug trial early on strong efficacy data Regulatory Affairs Professionals Society | RAPS
Impact of raising the upper extremity siding cardiac implantable electrical devices on postoperat...

Impact of raising the upper extremity siding cardiac implantable electrical devices on postoperative safety Wiley Online Library
How This Takeda Technology Exec Is Embracing The Possibilities 04/24/2025 - MediaPost

How This Takeda Technology Exec Is Embracing The Possibilities 04/24/2025 MediaPost
Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another - BioSpace

Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another BioSpace
Is Takeda Pharmaceutical Co. (TAK) Stock Undervalued Right Now? - Yahoo

Is Takeda Pharmaceutical Co. (TAK) Stock Undervalued Right Now? Yahoo
Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris - The Motley Fool

Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris The Motley Fool
A Six-Year-Old with a Rare Disease Finds Answers – and Treatment - Direct Relief

A Six-Year-Old with a Rare Disease Finds Answers – and Treatment Direct Relief
Poseida’s $6B blood relationship with Roche akin to Takeda deal in concept, strategy: CEO - BioWo...

Poseida’s $6B blood relationship with Roche akin to Takeda deal in concept, strategy: CEO BioWorld MedTech
FANUC COBOT EASES PAIN FOR TAKEDA PHARMACEUTICAL CO - Process and Control Today

FANUC COBOT EASES PAIN FOR TAKEDA PHARMACEUTICAL CO Process and Control Today
Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets - GlobeNewswire

Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets GlobeNewswire
Cipla signs agreement with Takeda to commercialise Vonoprazan - Express Pharma

Cipla signs agreement with Takeda to commercialise Vonoprazan Express Pharma
Takeda-Amgen treatment improves survival in metastatic colorectal cancer - BioWorld MedTech

Takeda-Amgen treatment improves survival in metastatic colorectal cancer BioWorld MedTech
Transition‐Metal‐Free Cross‐Coupling by Using Tertiary Benzylic Organoboronates - Wiley Online Li...

Transition‐Metal‐Free Cross‐Coupling by Using Tertiary Benzylic Organoboronates Wiley Online Library
Best Value Stocks to Buy for April 30th - TradingView

Best Value Stocks to Buy for April 30th TradingView
Figure 1. Functional role of Takeda G-protein-coupled receptor 5 (TGR5)... - ResearchGate

Figure 1. Functional role of Takeda G-protein-coupled receptor 5 (TGR5)... ResearchGate
Jumping Crystal of a Hydrogen-Bonded Organic Framework Induced by the Collective Molecular Motion...

Jumping Crystal of a Hydrogen-Bonded Organic Framework Induced by the Collective Molecular Motion of a Twisted π System Wiley Online Library
Takeda gives Sun Pharma, Cipla rights to commercialise gastro drug in India - ET Manufacturing

Takeda gives Sun Pharma, Cipla rights to commercialise gastro drug in India ET Manufacturing
Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term Remission of Complex Per...

Dibenzo[a,j]phenazine‐Cored Donor–Acceptor–Donor Compounds as Green‐to‐Red/NIR Thermally Activate...

Tri-Institutional Therapeutics Discovery Institute, Inc. Launched by Memorial Sloan-Kettering Can...

Entyvio by Takeda Pharmaceuticals - Pharmacy Times

Entyvio by Takeda Pharmaceuticals Pharmacy Times
Takeda, Frazier Healthcare Partners to launch Phathom Pharma - BioSpectrum Asia

Takeda, Frazier Healthcare Partners to launch Phathom Pharma BioSpectrum Asia
Mankind Pharma inks pact with Takeda to commercialise Vonoprazan in India - ET HealthWorld

Mankind Pharma inks pact with Takeda to commercialise Vonoprazan in India ET HealthWorld
Loss and Gain: Surviving the 2011 Tohoku Tsunami - commons.trincoll.edu

Loss and Gain: Surviving the 2011 Tohoku Tsunami commons.trincoll.edu
Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in Ind...

Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in India Express Pharma
Mankind Pharma inks pact with Takeda to commercialise acidity drug in India - Business Standard

Mankind Pharma inks pact with Takeda to commercialise acidity drug in India Business Standard
Mankind Pharma signs agreement with Takeda to commercialise novel drug for GERD treatment in Indi...

Mankind Pharma signs agreement with Takeda to commercialise novel drug for GERD treatment in India The Financial Express
TAKECAB® Now Available for the Treatment of Acid-related Diseases in Japan - otsuka.co.jp

TAKECAB® Now Available for the Treatment of Acid-related Diseases in Japan otsuka.co.jp